tradingkey.logo

Aclarion Inc

ACON
7.500USD
-0.330-4.21%
Fechamento 11/04, 16:00ETCotações atrasadas em 15 min
4.37MValor de mercado
PerdaP/L TTM

Mais detalhes de Aclarion Inc Empresa

Aclarion, Inc. is a healthcare technology company. The Company leverages magnetic resonance spectroscopy (MRS), and proprietary biomarkers to optimize clinical treatments. It has developed a software application called NOCISCAN. The product uses the existing MRS capabilities of many commercially available scanners to non-invasively analyze the chemical makeup of intervertebral discs in the spine. The software post-processes the MRS exam data and detects the presence of chemical biomarkers that the Company has demonstrated to be associated with degenerative pain and structural integrity of the lumbar discs. It uses a magnet to apply a pulsed magnetic field to a patient, sensors to detect radio waves that emanate from the resonant vibrations of different chemicals in the body in response to that pulsed magnetic field and a computer to create detailed images of tissue structures in the patient based on those detected chemical signals.

Informações de Aclarion Inc

Código da empresaACON
Nome da EmpresaAclarion Inc
Data de listagemApr 22, 2022
CEOMr. Brent Ness
Número de funcionários6
Tipo de títulosOrdinary Share
Fim do ano fiscalApr 22
Endereço8181 Arista Place
CidadeBROOMFIELD
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal80021
Telefone18332752266
Sitehttps://aclarion.com/
Código da empresaACON
Data de listagemApr 22, 2022
CEOMr. Brent Ness

Executivos da empresa Aclarion Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Brent Ness
Mr. Brent Ness
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
3.00
--
Mr. Ryan Bond
Mr. Ryan Bond
Chief Strategy Officer
Chief Strategy Officer
1.00
--
Mr. Gregory A. (Greg) Gould
Mr. Gregory A. (Greg) Gould
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Steve Deitsch
Mr. Steve Deitsch
Independent Director
Independent Director
--
--
Ms. Amanda Williams
Ms. Amanda Williams
Independent Director
Independent Director
--
--
Mr. William Wesemann
Mr. William Wesemann
Lead Independent Director
Lead Independent Director
--
--
Dr. Scott Breidbart, M.D.
Dr. Scott Breidbart, M.D.
Independent Director
Independent Director
--
--
Mr. David Neal
Mr. David Neal
Director
Director
--
--
Dr. Jeff Thramann, M.D.
Dr. Jeff Thramann, M.D.
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Brent Ness
Mr. Brent Ness
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
3.00
--
Mr. Ryan Bond
Mr. Ryan Bond
Chief Strategy Officer
Chief Strategy Officer
1.00
--
Mr. Gregory A. (Greg) Gould
Mr. Gregory A. (Greg) Gould
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Steve Deitsch
Mr. Steve Deitsch
Independent Director
Independent Director
--
--
Ms. Amanda Williams
Ms. Amanda Williams
Independent Director
Independent Director
--
--
Mr. William Wesemann
Mr. William Wesemann
Lead Independent Director
Lead Independent Director
--
--

Detalhamento da receita

Sem dados
Sem dados
Por Empresa
Por Região
Sem dados

Distribuição de ações

Atualizado em: sáb, 23 de ago
Atualizado em: sáb, 23 de ago
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
The Vanguard Group, Inc.
1.05%
Geode Capital Management, L.L.C.
0.32%
UBS Financial Services, Inc.
0.30%
Tower Research Capital LLC
0.01%
Outro
98.32%
Investidores
Investidores
Proporção
The Vanguard Group, Inc.
1.05%
Geode Capital Management, L.L.C.
0.32%
UBS Financial Services, Inc.
0.30%
Tower Research Capital LLC
0.01%
Outro
98.32%
Tipos de investidores
Investidores
Proporção
Investment Advisor
1.35%
Investment Advisor/Hedge Fund
0.32%
Hedge Fund
0.01%
Outro
98.32%

Participação acionária institucional

Atualizado em: qua, 1 de out
Atualizado em: qua, 1 de out
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q3
9
10.66K
1.68%
+7.30K
2025Q2
17
378.00
0.06%
-14.00
2025Q1
19
368.00
0.06%
+366.00
2024Q4
16
3.00
0.00%
-7.00
2024Q3
21
2.00
0.00%
-10.00
2024Q2
27
2.00
7.77%
-3.00
2024Q1
28
3.00
9.70%
--
2023Q4
35
1.00
14.29%
-1.00
2023Q3
34
1.00
25.00%
-1.00
2023Q2
33
1.00
25.00%
-1.00
Ver Mais

Atividade dos acionistas

Nome
Ações detidas
Proporção
Variação
Var. %
Data
The Vanguard Group, Inc.
1.71K
0.29%
--
--
Aug 31, 2025
Geode Capital Management, L.L.C.
1.59K
0.27%
+610.00
+62.37%
Aug 31, 2025
UBS Financial Services, Inc.
1.73K
0.3%
+1.68K
+3225.00%
Jun 30, 2025
Tower Research Capital LLC
75.00
0.01%
+72.00
+2400.00%
Jun 30, 2025
Thramann (Jeffrey John)
10.00
0%
+10.00
--
May 09, 2025
BofA Global Research (US)
8.00
0%
+4.00
+100.00%
Jun 30, 2025
Clear Street LLC
3.00
0%
--
--
Jun 30, 2025
Ness (Brent)
3.00
0%
+3.00
--
May 09, 2025
Neal (David K)
2.00
0%
+2.00
--
May 09, 2025
Wesemann (William G)
1.00
0%
+1.00
--
May 09, 2025
Ver Mais

ETFs Relacionados

Nome
Proporção
Sem dados

Dividendo

Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados

Desdobramento de ações

Data
Tipo
Proporção
Mar 26, 2025
Merger
27→1
Mar 26, 2025
Merger
27→1
Mar 26, 2025
Merger
27→1
Mar 26, 2025
Merger
27→1
Jan 24, 2025
Merger
335→1
Jan 24, 2025
Merger
335→1
Data
Tipo
Proporção
Mar 26, 2025
Merger
27→1
Mar 26, 2025
Merger
27→1
Mar 26, 2025
Merger
27→1
Mar 26, 2025
Merger
27→1
Jan 24, 2025
Merger
335→1
Jan 24, 2025
Merger
335→1
Jan 24, 2025
Merger
335→1
Jan 24, 2025
Merger
335→1
Jan 02, 2024
Merger
16→1
Jan 02, 2024
Merger
16→1
Ver Mais
KeyAI